On July 26, the California Department of Health Care Services (DHCS) and its Medi-Cal Rx contractor Magellan announced a delay in the first wave of reinstatement of prior authorizations for new start medications in 11 therapeutic drug classes from late August to Sept. 16.
This content is restricted to members.